Publications en collaboration avec des chercheurs de Hospital Universitario Puerta de Hierro (11)

2015

  1. Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer

    Oncotarget, Vol. 6, Núm. 38, pp. 40575-40587

  2. β-Cryptoxanthin synergistically enhances the antitumoral activity of oxaliplatin through ΔNP73 negative regulation in colon cancer

    Clinical Cancer Research, Vol. 21, Núm. 19, pp. 4398-4409

2014

  1. Tumor-derived exosomes are enriched in ΔNp73, which promotes oncogenic potential in acceptor cells and correlates with patient survival

    Human Molecular Genetics, Vol. 23, Núm. 2, pp. 467-478

2013

  1. Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients

    Cancer Science, Vol. 104, Núm. 4, pp. 437-444

  2. Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors

    Cancer Research, Vol. 73, Núm. 1, pp. 395-405

  3. Modulation of DNA-induced damage and repair capacity in humans after dietary intervention with lutein-enriched fermented milk.

    PloS one, Vol. 8, Núm. 9

  4. The TP73 complex network: Ready for clinical translation in cancer?

    Genes Chromosomes and Cancer, Vol. 52, Núm. 11, pp. 989-1006

2012

  1. Aberrant epigenetic regulation of bromodomain Brd4 in human colon cancer

    Journal of Molecular Medicine, Vol. 90, Núm. 5, pp. 587-595

2011

  1. EPAS1 mRNA in plasma from colorectal cancer patients is associated with poor outcome in advanced stages

    Oncology Letters, Vol. 2, Núm. 4, pp. 719-724

  2. Prognostic impact of ΔTAp73 isoform levels and their target genes in colon cancer patients

    Clinical Cancer Research, Vol. 17, Núm. 18, pp. 6029-6039

2010

  1. Differential regulation of TP73 isoforms by 1α,25-dihydroxyvitamin D3 and survivin in human colon and breast carcinomas

    Genes Chromosomes and Cancer, Vol. 49, Núm. 12, pp. 1135-1142